Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

9.19
+3.8471.78%
Volume:24.00M
Turnover:210.48M
Market Cap:5.52M
PE:-0.09
High:11.00
Open:7.00
Low:6.45
Close:5.35
52wk High:109.35
52wk Low:4.56
Shares:600.70K
Float Shares:593.10K
Volume Ratio:46.56
T/O Rate:4045.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:1.46
PE(LYR):-0.07

Loading ...

Top Midday Gainers

MT Newswires Live
·
1 hour ago

bioAffinity Technologies Inc trading halted, volatility trading pause

TIPRANKS
·
3 hours ago

BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung

TIPRANKS
·
Yesterday

bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's Cypath® Lung Noninvasive Lung Cancer Diagnostic

THOMSON REUTERS
·
Yesterday

bioAffinity Technologies - Cypath Lung Receives Dual Patent Protection in Hong Kong and China

THOMSON REUTERS
·
Yesterday

BioAffinity Technologies regains compliance with Nasdaq listing requirements

TIPRANKS
·
Sep 09

bioAffinity Technologies Regains Compliance with NASDAQ Listing Requirements

THOMSON REUTERS
·
Sep 09

bioAffinity Technologies Inc trading halted, volatility trading pause

TIPRANKS
·
Sep 04

NASDAQ Trade Halt Volatility Trading Pause at 11:06 Am

Reuters
·
Sep 04

bioAffinity CEO to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 04

U.S. Stocks on the MOVE-FuelCell, Gold Miners, NetApp

Reuters
·
Sep 03

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Sep 01

BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance

TIPRANKS
·
Sep 01

bioAffinity Advances CyPath Lung Test for Post-Treatment Lung Cancer Surveillance

Reuters
·
Sep 01

bioAffinity Technologies Advances Cypath® Lung for Surveillance of Lung Cancer Survivors

THOMSON REUTERS
·
Sep 01

NASDAQ Trade Halt Continues Reason not Available at 03:58 Am

Reuters
·
Aug 24

bioAffinity Technologies Inc trading halted, news pending

TIPRANKS
·
Aug 22

bioAffinity Technologies Effects 1-for-15 Reverse Stock Split Effective Aug. 24, 2026

Reuters
·
Aug 20

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026

THOMSON REUTERS
·
Aug 20

bioAffinity Signs AvMEDICAL Distribution Deal for CyPath Lung in Federal Healthcare Market

Reuters
·
Aug 18